British Journal of Pharmacology · 2002 · 133 citations · 26 references
MedicinePharmacologyPhysiologyPharmacodynamicsReproductive EndocrinologyReproductive PhysiologyAndrogen PhysiologyCardiovascular PhysiologyCirculatory PhysiologyHemodynamicsIon Channel PharmacologyTesticular PhysiologyConductanceNitric OxideNitric Oxide ModulationNitric Oxide ProductionNitric Oxide Synthase RegulationNitric Oxide-mediated VasodilationVasodilator Pharmacology
We have investigated the involvement of nitric oxide and K(+) channels in the vasorelaxant responses to physiologically-relevant concentrations of testosterone in the rat isolated mesenteric arterial bed. Testosterone (100 pM - 10 microM) elicited concentration-dependent relaxations in the isolated mesenteric arterial bed (pEC(50)=9.47 (9.22 - 9.73, 95% CI), maximal relaxation, R(max)=62.8+/-2.0%, n=6). A nitric oxide synthase (NOS) inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME, 300 microM) or removal of the endothelium significantly inhibited maximal relaxations to testosterone (L-NAME: R(max)=51.4+/-1.1%, P<0.01, n=6; endothelium-denuded: R(max)=46.9+/-2.8%, P<0.001, n=5). Raising the extracellular K(+) concentration to 30 and 60 mM, or pre-treatment with 300 microM tetrabutylammonium chloride (TBA), a calcium-activated K(+) channel inhibitor, abolished vasorelaxations induced by testosterone. A selective inhibitor of ATP-sensitive K(+) (K(ATP)) channels, glibenclamide (10 microM) and an inhibitor of voltage-sensitive K(+) (K(V)) channels, 4-aminopyridine (4-AP, 1 mM) did not affect testosterone-induced responses. Vasorelaxation to 1 microM testosterone was significantly (P<0.05) inhibited by 100 nM charybdotoxin (ChTx), an inhibitor of large conductance calcium-activated K(+) (BK(Ca)) channels (control: 63.3+/-9.9%, n=6; ChTx: 11.9+/-12.7%, n=3). Neither the testosterone receptor antagonist, flutamide (10 microM) nor an aromatase inhibitor, aminoglutethimide (10 microM) inhibited testosterone-induced responses. In conclusion, the present findings demonstrate, in the rat isolated mesenteric arterial bed, that testosterone causes acute vasorelaxations at physiologically relevant concentrations which are, in part, mediated via NO- and endothelium-dependent pathways. However, the activation of BK(Ca) channels plays a substantial role in testosterone-induced vasorelaxation.
26
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease
Carolyn Webb, John G. McNeill, Christopher S. Hayward et al. · Circulation · 1999 · 452 citations · Full text
Medicine, Cardiology, Endocrinology +17
Testosterone Relaxes Rabbit Coronary Arteries and Aorta
Ping Yue, Kanu Chatterjee, Carolyn M. Beale et al. · Circulation · 1995 · 415 citations
Acute Anti-Ischemic Effect of Testosterone in Men With Coronary Artery Disease
Giuseppe Rosano, Filippo Leonardo, Paolo Pagnotta et al. · Circulation · 1999 · 366 citations · Full text
Medicine, Cardiology, Endocrinology +15